莱维体病理在认知障碍个体的临床影响
Corinne Quadalti1, Sebastian Palmqvist2,3, Sara Hall2,3
1IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy.
Nature medicine
|July 18, 2023
概括
莱维体 (LB) 病理显著影响认知功能和临床衰退的患者认知障碍,独立于阿尔茨海默病 (AD) 生物标志物. 识别LB病理有助于预测患者的发展轨迹和指导治疗策略.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 生物标志物发现发现
背景情况:
- 对莱维体 (LB) 病理在认知障碍的临床影响的理解有限,特别是与同时存在的阿尔茨海默病 (AD) 病理.
- 需要精确的诊断工具来区分和管理重叠的神经退行性疾病.
研究的目的:
- 为了研究轻度认知障碍 (MCI) 或痴呆症患者的LB病理学的临床影响.
- 评估LB病理与认知衰退和特定症状的关联,独立于AD生物标志物.
- 评估LB病理作为认知障碍临床轨迹的预测因素.
主要方法:
- 在883名记忆诊所患者中,使用种子放大试验对错折叠的LB相关α-synuclein进行脑脊液 (CSF) 的分析.
- 评估临床数据,包括认知功能,幻觉和运动技能.
- 与AD生物标志物 (粉样β,) 和临床诊断相关的LB病理的截面和纵向分析.
主要成果:
- 23%的患者表现出LB病理,只有21%的人符合帕金森病或勒维体痴呆症的临床标准.
- 腰椎病理独立地与幻觉和注意力/执行,视觉空间和运动功能的缺陷有关.
- 腰椎病理学预测了所有领域的更快的纵向认知衰退,不论是AD生物标志物,认知阶段或基线诊断.
结论:
- 腰椎病理是认知障碍临床进展的重要独立预测因素.
- 检测LB病理为预测患者轨迹和告知临床管理提供了一种精准医学方法.
- 这些发现对设计针对阿尔茨海默氏症和LB疾病的向药物试验有意义.
相关概念视频
Parkinson's Disease: Overview
601
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
601
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


